Privia Health sets November 5 results date: what it means for Privia Health stock

Published on 10/14/2026 at 04:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 21.40 percent to USD 632.63 million in the second quarter of 2026. For Privia Health stock this means adjusted EBITDA rose 29.00 percent.

Results schedule and operating scale

On October 8, 2026, Privia announced a third-quarter release covering nine months ended September 30, 2026.
Second-quarter practice collections reached USD 970.00 million, up 12.40 percent year over year.
Management will host a conference call at 8:00 a.m. ET on November 5, 2026.

PRVA, US74276R1023, Illustration mit AI erstellt.

Privia Health Group, Inc. (ISIN US74276R1023) generated practice collections of USD 970.00 million in the second quarter of 2026, up 12.40 percent year over year, according to Benzinga on August 6, 2026. The company set November 5, 2026, for its third-quarter and nine-month results, making the next report the immediate test of its raised 2026 outlook.

Three milestones shape the story

The latest chronology starts with second-quarter results on August 6, 2026, when practice collections reached USD 970.00 million and adjusted EBITDA rose 29.00 percent year over year, according to Benzinga. On August 18, 2026, Privia announced one board appointment, according to Privia Health.

The current event arrived on October 8, 2026, when the company announced third-quarter results for the nine-month period ended September 30, 2026. Yahoo Finance reported that the release is scheduled before market open on November 5, 2026.

What does the growth mean?

Privia's second-quarter adjusted EBITDA reached USD 37.40 million, up 29.00 percent from the prior-year quarter, while first-half adjusted EBITDA rose 32.50 percent to USD 74.10 million, according to Benzinga. The same call cited more than USD 412.00 million in cash and no debt at the end of June, giving the company financial flexibility as it expands its provider network.

The operating model is scaling as well. Implemented providers reached 5,644 on June 30, 2026, up 10.10 percent year over year, while Privia's long-term target is adjusted EBITDA equal to 30.00 percent to 35.00 percent of care margin.

Stock value and next reporting date

Privia Health stock was last at USD 21.65 on Nasdaq on October 13, 2026, with a USD 18.92 to USD 28.82 52-week range and a market capitalization of USD 2.7 billion on that quote date. The company is classified in Healthcare and Medical Healthcare Information Services, and the November 5, 2026, report will provide the next dated operating checkpoint.